InvestSMART

Island Pharmaceuticals Limited (ASX:ILA)

ALERT: Price-sensitive ASX Announcement for ILA
Current share price for ILA : $0.370 -0.09 (-19.57%)+
Announcement
Release
26 Aug 2026 3:04PM
Price at Release
$0.460
Full Release
download
Summary
Island Pharmaceuticals Limited's Preliminary Final Report for the year ended 30 June 2026 reflects a significant increase in income from ordinary activities by 214.6% to $559,080. However, the company also reported a substantial rise in the loss from ordinary activities after tax, which increased by 151.1% to $9,843,987. There were no dividends paid, recommended, or declared during the financial year. The net tangible assets per ordinary security rose to 4.30 cents from 3.03 cents in the previous period. The financial statements were audited, receiving an unmodified opinion.
Key Points
  • Income from ordinary activities increased by 214.6% to $559,080.
  • Loss from ordinary activities after tax increased by 151.1% to $9,843,987.
  • No dividends paid, recommended, or declared during the period.
  • Net tangible assets per ordinary security increased to 4.30 cents.
  • Audited financial statements with an unmodified opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.